Close Menu

NEW YORK (GenomeWeb) — Fulgent Genetics reported after the close of the market on Tuesday a 15 percent increase in its first quarter revenues.

For the three-month period ended March 31, Fulgent posted revenues of $5.4 million versus $4.7 million in the same quarter last year. The firm said it delivered 7,530 billable genetic tests during Q1, a 63 percent year-over-year increase.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Sponsored by

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.